{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Sodium Nitroprusside is a prescription injectable medication used intravenously to rapidly lower high blood pressure in emergency situations, such as hypertensive crises. It works by relaxing blood vessels, helping to reduce strain on the heart. Manufactured by Meitheal Pharmaceuticals Inc. under ANDA211016, it's available as a 25 mg/mL solution. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Sodium nitroprusside \u2014 ANDA 211016 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211016", "mediaType": "text/html", "title": "Sodium nitroprusside"}], "identifier": "ANDA211016", "issued": "2016-09-16", "keyword": ["drug-safety", "medications", "pharmaceuticals", "prescription-drugs", "public-health"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Sodium nitroprusside"}